Prevalence of hepatitis C among pregnant women attending an inner london obstetric department: Uptake and acceptability of named antenatal testing

Gut

Volumn 47, Issue 2, 2000, Pages 277-280

  Ward, C ^a   Tudor Williams, G ^a   Cotzias, T ^a   Hargreaves, S ^b   Regan, L ^a   Foster, G R ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b Kensington Chelsea and Westminster ^*  (United Kingdom)

Author keywords

Hepatitis C; Pregnancy; Screening; Transmission

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; DRUG ABUSE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR;

FALSE POSITIVE REACTIONS; FEMALE; HEPATITIS C; HUMANS; INFORMED CONSENT; LONDON; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; PREVALENCE; RISK FACTORS; VIREMIA;

EID: 0033929974     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.2.277     Document Type: Article

References (17)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Badley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
3. WHO Consultation group. Global surveillance and control of heparitis C. J Viral Hepat 1999;6:1-15.
4. Alter MJ, Sampliner RE. Hepatitis C. N Engl J Med 1989;321:1538-40.
5. Hoofnagle JH. Hepatitis C: The clinical spectrum of disease. Hepatology 1997;(suppl 1)15-20S.
6. Manzini P, Saracco G, Cerchier A, et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; Persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunobloting pattern. Hepatology 1995;21:328-32.
7. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995;345:289-91.
8. Thomas S, Newell ML, Peckham C. Vertical transmission of hepatitis C virus and the potential role of antenatal screening. A review and systematic analysis. London: Institute of Child Health. Prepared for the Department of Health hepatitis C research initiative, 1997.
9. Boxall E, Skidmore S, Evans C, Nightingale S. The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol Infect 1994;113:523-8.
10. Floreani A, Paternoster D, Zappala F, et al. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 1997;103:325-9.
11. Pipan C, Amici S, Aston G, Ceci GP, Botta GA. Vertical transmission of hepatitis C virus in low risk pregnant women. Eur J Clin Microbiol Infect Dis 1996;15:116-20.
12. Roudot-Thoraval F, Pawlotsky JM, Deforges L, Girollet PP, Dhumeaux D. Anti-HCV seroprevalence in pregnant women in France. Gut 1993;(Suppl):S55-6.
13. Kane M, Alter M, Esteban R, Rizzetto M. Role of screening in prevention and treatment. Gut 1993(Suppl):S45-7.
14. Newell M-L, Thorne C, Pembrey, Nicoll A, Goldberg D, Peckham C. Antenatal screening for hepatitis B infection and syphilis in the UK. Br J Obstet Gynaecol 1999;106:66-71.
15. Foster GR, Goldin R, Main J, Murray-Lyon I, Hargreaves S, Thomas HC. The management of chronic hepatitis C: clinical audit of a biopsy based management algorithm. BMJ 1997;315:453-8.
16. McHutchison JG, Gordon, Schiff MR, et al. Interferon alpha 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1999;339:1485-92.
17. Spencer J, Latt N, Beeby P, Saunders J, McCaughan G, Cossart Y. Transmission of hepatitis C to mothers of infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat 1997;4:395-409.